Take a look at some of Thursday morning’s early movers:

Guess? - The clothing maker is forecasting first-quarter earnings of 25 to 28 cents per share, well below estimates of 48 cents. It says consumers in Europe have been hit hard by austerity measures, which will impact a company that gets 40 percent of its total revenue from Europe.

Capital One - The company is announcing a $1.25 billion common stock offering, with the proceeds being used to fund its previously announced acquisition of HSBC’s U.S. credit-card business. It also said it expects first-quarter earnings per share of $1.35, excluding certain items, two cents below current Wall Street estimates.

Yahoo! - Hedge fund Third Point says it will begin a proxy fight within a week to put four directors on Yahoo’s board. Third Point says Yahoo’s lack of responsiveness to its proposed directors leave it no choice but to begin that fight. Yahoo says it’s giving fair consideration to all director nominees.

Sanofi - The shares could benefit today, as drugmaker Shire has pulled its U.S. application to sell its Replagal, a treatment for Fabry disease. Sanofi’s Genzyme unit makes Replagal competitor Fabrazyme.

SNY News & Analysis

 UPDATE 1-FDA staff says Merck's sleep drug effective, questions dosage - 18 hrs ago

 Amyris slips after firm starts securities lawsuit - 16 May 2013 EDT

 FDA approves labels with lower doses for zolpidem sleep drugs - 14 May 2013 EDT

 A taste for defensives sours prospects for European stocks - 14 May 2013 EDT

 Drug Spending Drops for the First Time in 55 Years - 09 May 2013 EDT

 More SNY News